AstraZeneca, EU both claim victory in tussle over deliveries – News Vibe24

    AstraZeneca, EU both claim victory in tussle over deliveries - Times of India
    BRUSSELS: AstraZeneca and the European Union challenged victory on Friday in a legal dispute over allegations that the Koranic vaccine maker did not produce shots for the 27-nation bloc.
    AstraZeneca was seen as a key pillar of vaccine distribution in the EU. Its contract with the Commission provided for the initial distribution of 300 million doses, with an option for another 100 million, but the speed of deliveries was much slower than the company initially thought.
    AstraZeneca says a judge in Brussels has ordered 80.2 million doses of the vaccine to be delivered by 27 September 2021. The EU executive, the European Commission, had asked the pharmacist to deliver a total of 120 million doses of the vaccine by the end of June.
    “We are pleased with the Court’s ruling,” said Jeffrey Pott, the company’s Executive Vice President, in a statement. “AstraZeneca has fully complied with its agreement with the European Commission and we will continue to focus on the urgent task of providing an effective vaccine.”
    The Commission, for its part, also claimed that it had won that the judge had ordered the company to meet the delivery schedule of 15 million installments by 26 July, 20 million installments by 23 August and 15 million installments by 27 September. fine 10 euros ($ 12) per installment not delivered.
    “This decision confirms the Commission’s position: AstraZeneca has not complied with its commitments under the contract. It is good to see that an independent judge confirms this,” said Commission President Ursula von der Leyen.
    “This shows that our European vaccination campaign not only offers our citizens day by day. It also shows that it was based on a sound legal basis,” he said in a statement.
    For its part, AstraZeneca also noted that the judge had acknowledged the difficulties in meeting a strict supply schedule “in this unprecedented situation”.
    “AstraZeneca is now looking forward to a new partnership with the European Commission to combat the pandemic in Europe,” the Anglo-Swedish company said.